NASDAQ: IDXX
Idexx Laboratories Inc Stock

$518.10+6.11 (+1.19%)
Updated May 16, 2025
IDXX Price
$518.10
Fair Value Price
$153.40
Market Cap
$41.67B
52 Week Low
$356.14
52 Week High
$545.43
P/E
47.45x
P/B
28.78x
P/S
8.69x
PEG
3.93x
Dividend Yield
N/A
Revenue
$3.93B
Earnings
$894.97M
Gross Margin
61.3%
Operating Margin
29.39%
Profit Margin
22.8%
Debt to Equity
1.22
Operating Cash Flow
$968M
Beta
1.15
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

IDXX Overview

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine IDXX's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Diagnostic & Research

Industry Rating
C
IDXX
Ranked
#9 of 43

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$42.65A
$12.90A
$12.80B
View Top Diagnostic & Research Stocks

Be the first to know about important IDXX news, forecast changes, insider trades & much more!

IDXX News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IDXX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IDXX ($518.10) is overvalued by 237.75% relative to our estimate of its Fair Value price of $153.40 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
IDXX ($518.10) is not significantly undervalued (237.75%) relative to our estimate of its Fair Value price of $153.40 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
IDXX ($518.10) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more IDXX due diligence checks available for Premium users.

Valuation

IDXX fair value

Fair Value of IDXX stock based on Discounted Cash Flow (DCF)

Price
$518.10
Fair Value
$153.40
Overvalued by
237.75%
IDXX ($518.10) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
IDXX ($518.10) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
IDXX ($518.10) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IDXX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
47.45x
Industry
20.26x
Market
25.95x
IDXX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IDXX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

IDXX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
28.78x
Industry
3.43x
IDXX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IDXX price to earnings growth (PEG)

For valuing profitable companies with growth potential

IDXX is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

IDXX's financial health

Profit margin

Revenue
$998.4M
Net Income
$242.7M
Profit Margin
24.3%
IDXX's Earnings (EBIT) of $1.16B... subscribe to Premium to read more.
Interest Coverage Financials
IDXX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.2B
Liabilities
$1.8B
Debt to equity
1.22
IDXX's short-term assets ($1.32B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IDXX's short-term assets ($1.32B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IDXX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IDXX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$238.0M
Investing
-$29.6M
Financing
-$330.3M
IDXX's operating cash flow ($968.38M)... subscribe to Premium to read more.
Debt Coverage Financials

IDXX vs Diagnostic & Research Stocks

TickerZen RatingMarket Cap1d %P/EP/B
IDXXB$41.67B+1.19%47.45x28.78x
AB$32.44B+1.22%26.03x5.38x
IQVC$24.71B+1.70%19.27x4.13x
MTDC$24.05B+1.23%28.77x-132.18x
WATB$21.39B+2.24%32.50x10.90x

Idexx Laboratories Stock FAQ

What is Idexx Laboratories's quote symbol?

(NASDAQ: IDXX) Idexx Laboratories trades on the NASDAQ under the ticker symbol IDXX. Idexx Laboratories stock quotes can also be displayed as NASDAQ: IDXX.

If you're new to stock investing, here's how to buy Idexx Laboratories stock.

What is the 52 week high and low for Idexx Laboratories (NASDAQ: IDXX)?

(NASDAQ: IDXX) Idexx Laboratories's 52-week high was $545.43, and its 52-week low was $356.14. It is currently -5.01% from its 52-week high and 45.48% from its 52-week low.

How much is Idexx Laboratories stock worth today?

(NASDAQ: IDXX) Idexx Laboratories currently has 80,421,917 outstanding shares. With Idexx Laboratories stock trading at $518.10 per share, the total value of Idexx Laboratories stock (market capitalization) is $41.67B.

Idexx Laboratories stock was originally listed at a price of $3.99 in Dec 31, 1997. If you had invested in Idexx Laboratories stock at $3.99, your return over the last 27 years would have been 12,901.25%, for an annualized return of 19.76% (not including any dividends or dividend reinvestments).

How much is Idexx Laboratories's stock price per share?

(NASDAQ: IDXX) Idexx Laboratories stock price per share is $518.10 today (as of May 16, 2025).

What is Idexx Laboratories's Market Cap?

(NASDAQ: IDXX) Idexx Laboratories's market cap is $41.67B, as of May 18, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Idexx Laboratories's market cap is calculated by multiplying IDXX's current stock price of $518.10 by IDXX's total outstanding shares of 80,421,917.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.